News

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).
The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to a study ...
A review of 57 clinical trials shows traditional Chinese medicine shortens fever duration, improves lung recovery, and ...
Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...
No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...
Public health leaders looked to UNC-Chapel Hill virologist Ralph Baric to end the pandemic. Their critics blamed it on him.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...
CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has ...
Equities researchers at StockNews.com initiated coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a research note issued on Friday. The brokerage set a “sell” rating on the stock.
Enrollment ongoing in Phase 2 KOURAGE trial of Auxora in acute kidney injury (AKI) and respiratory failure; data expected around the end of 2025 Post-hoc analysis of ...